SCHEMBL7570063

SCHEMBL7570063

CCc1cc[c]c(-c2ccc(OC)cc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
ALDH1A1 P00352 2/20 0.39
MAOB P27338 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALOX15 P16050 1/20 0.39
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
EGFR P00533 1/20 0.38
TP53 P04637 3/20 0.37
NPC1 O15118 1/20 0.37
MAPK1 P28482 1/20 0.37
CASP3 P42574 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27978147 0.85 MAOB (0.45) MAPTALDH1A1MAOBKDM4EALOX15
SCHEMBL8088676 0.84 NOTUM (0.39) MAPTALDH1A1EGFRTP53NPC1
SCHEMBL8089726 0.83 MAPT (0.38) MAPTALDH1A1MAOBHPGDHSD17B10
SCHEMBL8525746 0.81 ALDH1A1 (0.56) MAPTALDH1A1KDM4EALOX15HPGD
SCHEMBL5320671 0.81 HSD17B10 (0.33) MAPTALDH1A1KDM4EHPGDHSD17B10
SCHEMBL459934 0.80 CA12 (0.44) MAPTALDH1A1MAOBKDM4EHPGD
SCHEMBL4463655 0.79 MAPT (0.32) MAPTALDH1A1KDM4EEGFRTP53
SCHEMBL9075188 0.79 GSTP1 (0.47) MAOBCA12CA1CA2CA7
SCHEMBL27720539 0.79 ABL1 (0.47) MAOBEGFRTP53NPC1MAPK1
SCHEMBL28095381 0.79 ABL1 (0.47) MAOBEGFRTP53NPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020016361-A1 Beta-amino acid nitrile derivatives as cathepsin K inhibitors HOFFMANN-LA ROCHE INC. 2002-02-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020016361-A1 Beta-amino acid nitrile derivatives as cathepsin K inhibitors CTSK, CTSH, UACA MAPT 1879/4885ALDH1A1 3459/4885MAOB 738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.